All services

CEA — carcinoembryonic antigen

CEA is used mainly in colorectal tumours. Its chief value is not in initial diagnosis but in follow-up: a fall after surgery and a later rise allow recurrence to be detected early.

  • 🩸 5-minute blood draw
  • ⏰ samples 08:00–13:00
  • 📄 result by messenger
  • 🏥 in-house laboratory

CA 125

CA 125 is the main tumour marker for ovarian cancer. It is measured when an ovarian mass is found and for monitoring during treatment; together with HE4 it is used to calculate the ROMA index.

  • 🩸 5-minute blood draw
  • ⏰ samples 08:00–13:00
  • 📄 result by messenger
  • 🏥 in-house laboratory

CA 19-9

CA 19-9 is associated primarily with tumours of the pancreas and bile ducts. It also rises in jaundice and inflammation, so it is interpreted only alongside imaging findings.

  • 🩸 5-minute blood draw
  • ⏰ samples 08:00–13:00
  • 📄 result by messenger
  • 🏥 in-house laboratory

CA 15-3

CA 15-3 is used to monitor patients with breast cancer: its trend shows how well treatment is working and detects recurrence in good time. The marker is not used for early diagnosis.

  • 🩸 5-minute blood draw
  • ⏰ samples 08:00–13:00
  • 📄 result by messenger
  • 🏥 in-house laboratory

CA 72-4

CA 72-4 is used mainly in gastric tumours, often in combination with other markers. Like other tumour markers it is used for monitoring rather than primary screening.

  • 🩸 5-minute blood draw
  • ⏰ samples 08:00–13:00
  • 📄 result by messenger
  • 🏥 in-house laboratory
Website development — KLINIKI.UZ